Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)
9.12
-0.33 (-3.49%)
Jun 19, 2025, 2:45 PM CST
SHE:301060 Revenue
Shanghai Labway Clinical Laboratory had revenue of 350.88M CNY in the quarter ending March 31, 2025, a decrease of -19.60%. This brings the company's revenue in the last twelve months to 1.66B, down -2.45% year-over-year. In the year 2024, Shanghai Labway Clinical Laboratory had annual revenue of 1.74B with 4.05% growth.
Revenue (ttm)
1.66B
Revenue Growth
-2.45%
P/S Ratio
2.19
Revenue / Employee
1.21M
Employees
1,365
Market Cap
3.63B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.74B | 67.81M | 4.05% |
Dec 31, 2023 | 1.67B | -2.52B | -60.13% |
Jan 1, 2023 | 4.20B | 2.42B | 136.14% |
Jan 1, 2022 | 1.78B | 540.14M | 43.62% |
Dec 31, 2020 | 1.24B | 84.69M | 7.34% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |